Benjamin Edwards’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$408K Buy
11,145
+4,947
+80% +$179K ﹤0.01% 1139
2026
Q2
$219K Buy
+6,198
New +$183K ﹤0.01% 1345

Other funds holding ROIV

Benjamin Edwards's ROIV Position: Q3 2026 in Review

Benjamin Edwards increased its Roivant Sciences (ROIV) stake by 80% in Q3 2026, buying an estimated $179K and bringing the position to 11,145 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Benjamin Edwards first reported a position in ROIV in Q2 2026 and has held it in 2 quarters since. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Benjamin Edwards held 11,145 shares of Roivant Sciences worth $408K as of Q3 2026.
  • Benjamin Edwards bought 4,947 Roivant Sciences shares in Q3 2026, an estimated $179K.
  • Roivant Sciences made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1139 holding.
  • Benjamin Edwards first reported a position in Roivant Sciences in Q2 2026 and has held it in 2 quarters since.
  • 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.